|
1.
|
|
13 p, 630.1 KB |
Effectiveness of family metacognitive training in mothers with psychosis and their adolescent children : a multicenter study protocol
/
Ochoa, Susana (Institut de Recerca Sant Joan de Déu) ;
Espinosa, Victoria (Institut de Recerca Sant Joan de Déu) ;
López-Carrilero, Raquel (Institut de Recerca Sant Joan de Déu) ;
Martinez, Irene (Parc Sanitari Sant Joan de Déu) ;
Barrera, Alejandro De Haro (Parc Sanitari Sant Joan de Déu) ;
Birulés, Irene (Universistat de Barcelona) ;
Barajas Vélez, Ana (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica I de la Salut) ;
Pélaez, Trinidad (Centro de Investigación Biomédica en Red de Salud Mental) ;
Díaz-Cutraro, Luciana (Universitat Ramon Llull) ;
Coromina, Marta (Parc Sanitari Sant Joan de Déu) ;
González-Rodríguez, Alexandre (Hospital Universitari MútuaTerrassa) ;
Verdaguer-Rodríguez, Marina (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica I de la Salut) ;
Gutiérrez-Zotes, Alfonso (Hospital Universitari de Tarragona Joan XXIII) ;
Palma-Sevillano, Carolina (Hospital de Mataró) ;
Montes, Cristian (Hospital Universitario Virgen del Rocio) ;
Gallego, Judith (Fundació Vidal i Barraquer) ;
Paya, Beatriz (Universidad de Cantabria) ;
Casanovas, Francesc (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Roldán, María (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Noval, Emma (Universidad de Cantabria) ;
Varela Casal, Paloma (Hospital de Mataró) ;
Salas-Sender, Miriam (Fundació Vidal i Barraquer) ;
Aznar, Ana (Associació Centre Higiene Mental Les Corts (Barcelona, Catalunya)) ;
Ayesa-Arriola, Rosa (Universidad de Cantabria) ;
Pousa, Esther (Institut de Recerca Sant Pau) ;
Canal-Rivero, Manuel (Universidad de Sevilla) ;
Garrido-Torres, Nathalia (Universidad de Sevilla) ;
Montserrat, Clara (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Muñoz-Lorenzo, Laura (IIS-Fundación Jiménez Díaz) ;
Crosas, Josep Maria (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
More than half of women with psychosis take care of their children despite the difficulties caused by the disease. Additionally, these kids have a higher risk of developing a mental health disorder. [...]
2024 -  10.3389/fpsyg.2024.1359693
Frontiers in psychology, Vol. 15 (march 2024)
|
|
|
2.
|
|
2 p, 292.1 KB |
Corrigendum : The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)
/
Navarro-Compán, Victoria (Hospital Universitario La Paz) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ;
Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ;
Llamas-Velasco, Mar (Hospital Universitario de la Princesa (Madrid)) ;
Fernández-Carballido, Cristina (Hospital Universitario San Juan de Alicante) ;
Almodóvar, Raquel (Hospital Universitario Fundación Alcorcón) ;
Pinto, José Antonio (Complejo Hospitalario Universitario de A Coruña) ;
Galíndez-Aguirregoikoa, Eva (Hospital Universitario de Basurto) ;
Zarco, Pedro (Hospital Universitario Fundación Alcorcón) ;
Joven, Beatriz (Hospital 12 de Octubre (Madrid)) ;
Gratacós, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Juanola, Xavier (Hospital Universitari de Bellvitge) ;
Blanco, Ricardo (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Arias-Santiago, Salvador (Universidad de Granada) ;
Sanz Sanz, Jesús (Hospital Universitario Puerta del Hierro Majadahonda) ;
Queiro, Ruben (Hospital Universitario Central de Asturias) ;
Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
In the published article, there was an error in Table 1 as published. The cell corresponding to ixekizumab in HS must be yellow rather than green, since it is not approved for that indication, nor has phase 3 clinical development been published. [...]
2023 - 10.3389/fimmu.2023.1332177
Frontiers in immunology, Vol. 14 (2023) , p. 1332177
|
|
|
3.
|
|
13 p, 1.4 MB |
Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU : a multicenter observational retrospective study
/
Wendel-Garcia, Pedro David (University Hospital of Zurich) ;
Mas, Arantxa (Hospital de Sant Joan Despí Moisès Broggi) ;
González-Isern, Cristina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Ferrer, Ricard (Hospital Universitari Vall d'Hebron) ;
Máñez, Rafael (Hospital Universitari de Bellvitge) ;
Masclans, Joan R. (Hospital del Mar (Barcelona, Catalunya)) ;
Sandoval, Elena (Hospital Clínic I Provincial de Barcelona) ;
Vera, Paula (Institut d'Investigació Biomèdica Sant Pau) ;
Trenado, Josep (Hospital Universitari MútuaTerrassa) ;
Fernández, Rafael (Fundació Althaia) ;
Sirvent, Josep Maria (Hospital Universitari de Girona Doctor Josep Trueta) ;
Martínez, Melcior (Hospital General De Cataluña) ;
Ibarz, Mercedes (Hospital Universitari Sagrat Cor) ;
Garro, Pau (Hospital General de Granollers) ;
Lopera, José Luis (Hospital General de Vic) ;
Bodí, María (Hospital Universitari Joan XXIII de Tarragona) ;
Yébenes-Reyes, Joan Carles (Hospital de Mataró) ;
Triginer, Carles (Hospital d'Igualada) ;
Vallverdú, Imma (Hospital Sant Joan de Reus) ;
Baró, Anna (Hospital de Santa Caterina (Salt)) ;
Bodí, Fernanda (Hospital de Sant Pau I Santa Tecla) ;
Saludes, Paula (Hospital HM Nou Delfos) ;
Valencia, Mauricio (Hospital El Pilar) ;
Roche-Campo, Ferran (Hospital de Tortosa Verge de La Cinta) ;
Huerta,Arturo (Clínica Sagrada Família) ;
Cambra, Francisco José (Hospital de Sant Joan de Déu (Manresa, Catalunya)) ;
Barberà, Carme (Hospital Santa María) ;
Echevarría, Jorge (Hospital ASEPEYO de Barcelona) ;
Peñuelas, Óscar (Hospital, Universitario de Getafe) ;
Mancebo, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Roca, Oriol (Hospital Universitari Vall d'Hebron) ;
Nuvials, Xavier (Hospital Universitari Vall d'Hebron) ;
Ruiz, Juan Carlos (Hospital Universitari Vall d'Hebron) ;
Papiol, Elisabeth (Hospital Universitari Vall d'Hebron) ;
Máñez, Rafael (Hospital Universitari de Bellvitge) ;
Gumicio, Víctor Daniel (Hospital Universitari de Bellvitge) ;
Muñoz, Guillermo (Hospital Clínic I Provincial de Barcelona) ;
Toapanta, David (Hospital Clínic I Provincial de Barcelona) ;
Castro Rebollo, Pedro (Hospital Clínic I Provincial de Barcelona) ;
Osorio, J. (Hospital Clínic I Provincial de Barcelona) ;
Muñoz-Bermúdez, Rosana (Hospital del Mar (Barcelona, Catalunya)) ;
Parrilla-Gómez, Francisco José (Hospital del Mar (Barcelona, Catalunya)) ;
Pérez-Terán, Purificación (Hospital del Mar (Barcelona, Catalunya)) ;
Marin-Corral, Judith (Hospital del Mar (Barcelona, Catalunya)) ;
Cancio, Beatriz (Hospital de Sant Joan Despí Moisès Broggi) ;
Hernández-Marín, Susana (Hospital de Sant Joan Despí Moisès Broggi) ;
Koborzan, M.R. (Hospital de Sant Joan Despí Moisès Broggi) ;
Briones, Carlos. (Hospital de Sant Joan Despí Moisès Broggi) ;
Sebastian, Patricia (Hospital Universitari de Girona Doctor Josep Trueta) ;
Saiz, Xavier (Hospital Universitari de Girona Doctor Josep Trueta) ;
Pedrós, Cristina (Hospital General de Granollers) ;
Vendrell, E. (Hospital General de Granollers) ;
Rodríguez, Alejandro (Hospital Universitari Joan XXIII de Tarragona) ;
Moreno, G. (Hospital Universitari Joan XXIII de Tarragona) ;
Morales, Montserrat (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Cervelló, Joaquim Ramón (Hospital HM Nou Delfos) ;
Franch-Llasat, Diego (Hospital de Tortosa Verge de La Cinta) ;
Santigosa, Pilar (Clínica Sagrada Família) ;
Benito Fernández, Sergio (Hospital de Sant Joan de Déu (Manresa, Catalunya)) ;
Santos, José Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Baldirà, Jaume (Institut d'Investigació Biomèdica Sant Pau) ;
Betbesé Roig, Antoni Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Izura Gómez, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Morán, Indalecio (Institut d'Investigació Biomèdica Sant Pau) ;
Suárez, Juan Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Zapata, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez, Nuria (Institut d'Investigació Biomèdica Sant Pau) ;
Torrens, Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Cordón, Alejandra (Institut d'Investigació Biomèdica Sant Pau) ;
Gomila, C. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Flores Castillo, Mitsury Jacqueline (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Segarra Casas, Alba (Institut d'Investigació Biomèdica Sant Pau) ;
Mateo, Laura (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Martos, Mikel (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Background: Non-invasive oxygenation strategies have a prominent role in the treatment of acute hypoxemic respiratory failure during the coronavirus disease 2019 (COVID-19). While the efficacy of these therapies has been studied in hospitalized patients with COVID-19, the clinical outcomes associated with oxygen masks, high-flow oxygen therapy by nasal cannula and non-invasive mechanical ventilation in critically ill intensive care unit (ICU) patients remain unclear. [...]
2022 - 10.1186/s13054-022-03905-5
Critical Care, Vol. 26 Núm. 1 (december 2022) , p. 37
|
|
|
4.
|
|
23 p, 1.3 MB |
European guideline (EuroGuiDerm) on atopic eczema - part II : non-systemic treatments and treatment recommendations for special AE patient populations
/
Wollenberg, Andreas (Brussels University Hospital) ;
Kinberger, Maria (Charité - Berlin University Medicine) ;
Arents, B. (European Federation of Allergy and Airways Diseases Patients' Associations) ;
Aszodi, N. (LMU Munich) ;
Avila Valle, G. (Charité - Berlin University Medicine) ;
Barbarot, Sebastien (Nantes University) ;
Bieber, T. (University Hospital of Bonn) ;
Brough, H.A. (King's College London) ;
Calzavara Pinton, P. (University of Brescia) ;
Christen-Zäch, S. (Lausanne University Hospital) ;
Deleuran, M. (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Dittmann, M. (Charité - Berlin University Medicine) ;
Dressler, C. (Charité - Berlin University Medicine) ;
Fink-Wagner, A.H. (Global Allergy and Airways diseases Patient Platform) ;
Fosse, N. (University Hospital Basel) ;
Gáspár, K. (University of Debrecen) ;
Gerbens, L. (Amsterdam UMC) ;
Gieler, U. (University of Giessen) ;
Girolomoni, Giampiero (University of Verona) ;
Gregoriou, S. (National and Kapodistrian University of Athens) ;
Mortz, C. G. (University of Southern Denmark) ;
Nast, A. (Charité - Berlin University Medicine) ;
Nygaard, U. (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Redding, M. (Eczema Outreach Support) ;
Rehbinder, E.M. (Oslo University Hospital) ;
Ring, J. (Technical University Munich) ;
Rossi, M. (Spedali Civili Hospital Brescia) ;
Serra-Baldrich, E (Institut d'Investigació Biomèdica Sant Pau) ;
Simon, D. (University of Bern) ;
Szalai, Z.Z. (Heim Pál National Children's Institute Budapest) ;
Szepietowski, J.C. (Wrocław Medical University) ;
Torrelo, A. (Hospital Infantil Niño Jesús) ;
Werfel, T. (Hannover Medical School) ;
Flohr, C. (Guy's & St Thomas' NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. [...]
2022 - 10.1111/jdv.18429
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 11 (november 2022) , p. 1904-1926
|
|
|
5.
|
|
16 p, 5.9 MB |
Adipokines as New Biomarkers of Immune Recovery : Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
/
Yeregui, Elena (Instituto de Salud Carlos III) ;
Masip, J. (Instituto de Salud Carlos III) ;
Viladés, C. (Instituto de Salud Carlos III) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Pacheco, Y.M. (Universidad de Sevilla) ;
Blanco, J. (Universitat de Vic - Universitat Central de Catalunya) ;
Mallolas Masferrer, Josep (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Alba, Verónica (Instituto de Salud Carlos III) ;
Vargas, M. (Instituto de Salud Carlos III) ;
García-Pardo, G. (Instituto de Salud Carlos III) ;
Negredo Puigmal, Eugènia (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Olona, M. (Instituto de Salud Carlos III) ;
Vidal-González, J. (Universitat de Barcelona) ;
Peraire, M. (Universitat Rovira i Virgili) ;
Martí, A. (Instituto de Salud Carlos III) ;
Reverté, L. (Instituto de Salud Carlos III) ;
Gómez-Bertomeu, F. (Instituto de Salud Carlos III) ;
Leal, M. (Hospital Viamed Santa Ángela de la Cruz) ;
Vidal, F. (Instituto de Salud Carlos III) ;
Peraire, J. (Instituto de Salud Carlos III) ;
Rull, A. (Instituto de Salud Carlos III) ;
Universitat Autònoma de Barcelona
A significant proportion of people living with HIV (PLHIV) who successfully achieve virological suppression fail to recover CD4 T-cell counts. Since adipose tissue has been discovered as a key immune organ, this study aimed to assess the role of adipokines in the HIV immunodiscordant response. [...]
2022 - 10.3390/ijms23042202
International journal of molecular sciences, Vol. 23 Núm. 4 (2-2 2022) , p. 2202
|
|
|
6.
|
|
19 p, 1.5 MB |
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
/
Wieduwilt, M.J. (University of Oklahoma) ;
Metheny, L. (University Hospitals Seidman Cancer Center) ;
Zhang, M.J. (Medical College of Wisconsin) ;
Wang, H.L. (Center for International Blood and Marrow Transplant Research) ;
Estrada-Merly, N. (Center for International Blood and Marrow Transplant Research) ;
Marks, D.I. (University Hospitals Bristol National Health Service Trust) ;
Samer Al-Homsi, A. (New York University Langone Health) ;
Muffly, L. (Stanford University) ;
Chao, N. (Duke University Medical Center) ;
Rizzieri, D. (Duke University) ;
Gale, R.P. (Imperial College London) ;
Gadalla, S.M. (National Institutes of Health) ;
Cairo, M. (New York Medical College) ;
Mussetti, Alberto (Institut d'Investigacio Biomedica de Bellvitge) ;
Gore, S. (Yale New Haven Hospital) ;
Bhatt, V.R. (University of Nebraska Medical Center) ;
Patel, S.S. (University of Utah) ;
Michelis, F.V. (Princess Margaret Cancer Centre) ;
Inamoto, Y. (National Cancer Center Hospital) ;
Badawy, S.M. (Northwestern University Feinberg School of Medicine) ;
Copelan, E. (Atrium Health) ;
Palmisiano, N. (Thomas Jefferson University) ;
Kharfan-Dabaja, M.A. (Mayo Clinic) ;
Lazarus, H.M. (Case Western Reserve University) ;
Ganguly, S. (University of Kansas Health System) ;
Bredeson, C. (The Ottawa Hospital Transplant and Cellular Therapy Program) ;
Perez, M.A.D. (Hospital Infantil Universitario Niño Jesus) ;
Cassaday, R. (University of Washington) ;
Savani, B.N. (Vanderbilt University Medical Center) ;
Ballen, K. (Division of Hematology/Oncology. University of Virginia Health System) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Wirk, B. (Penn State Cancer Institute) ;
Bacher, U. (University of Bern) ;
Aljurf, Mahmoud (King Faisal Specialist Hospital Center and Research) ;
Bashey, A. (Northside Hospital) ;
Murthy, H.S. (Mayo Clinic) ;
Yared, J.A. (University of Maryland) ;
Aldoss, I. (City of Hope Medical Center) ;
Farhadfar, N. (University of Florida College of Medicine) ;
Liu, H. (University of Chicago Medicine) ;
Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ;
Waller, E.K. (Emory University) ;
Solh, M. (Northside Hospital) ;
Seftel, M.D. (University of British Columbia) ;
van der Poel, M. (Maastricht University Medical Center) ;
Grunwald, M.R. (Atrium Health) ;
Liesveld, J.L. (University of Rochester Medical Center) ;
Kamble, R.T. (Baylor College of Medicine) ;
McGuirk, J. (University of Kansas Health System) ;
Munker, R. (University of Kentucky) ;
Cahn, J.Y. (Universite Grenoble Alpes) ;
Lee, J.W. (The Catholic University of Korea) ;
Freytes, C.O. (University of Texas Health Science Center) ;
Krem, M.M. (University of Kentucky) ;
Winestone, L.E. (University of California) ;
Gergis, U. (Thomas Jefferson University) ;
Nathan, S. (Rush University Medical Center) ;
Olsson, R.F. (Karolinska Institutet) ;
Verdonck, L.F. (Isala Clinic) ;
Sharma, A. (St. Jude Children's Research Hospital) ;
Ringden, O. (Karolinska Institutet) ;
Friend, B.D. (Baylor College of Medicine) ;
Cerny, J. (University of Massachusetts Medical Center) ;
Choe, H. (The Ohio State University Wexner Medical Center) ;
Chhabra, S. (Center for International Blood and Marrow Transplant Research) ;
Nishihori, T. (Moffitt Cancer Center) ;
Seo, S. (Dokkyo Medical University) ;
George, B. (Christian Medical College) ;
Baxter-Lowe, L.A. (Children's Hospital Los Angeles) ;
Hildebrandt, G.C. (University of Kentucky) ;
de Lima, M. (University Hospitals Case Medical Center) ;
Litzow, M. (Mayo Clinic Rochester) ;
Kebriaei, P. (The University of Texas MD Anderson Cancer Center) ;
Hourigan, C.S. (National Institutes of Health) ;
Abid, M.B. (Medical College of Wisconsin) ;
Weisdorf, D.J. (University of Minnesota) ;
Saber, W. (Center for International Blood and Marrow Transplant Research) ;
Universitat Autònoma de Barcelona
The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We performed a retrospective, multivariable analysis comparing outcomes of HCT approaches by donor for adults with ALL in remission. [...]
2022 - 10.1182/bloodadvances.2021004916
Blood advances, Vol. 6 Núm. 1 (november 2022) , p. 339-357
|
|
|
7.
|
|
9 p, 1.5 MB |
Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory Patient Inmunosenescencia, fitness inmunológico y calendario de vacunación en el paciente respiratorio adulto
/
Villar-Álvarez, F. (Universidad Autónoma of Madrid) ;
de la Rosa Carrillo, David (Institut d'Investigació Biomèdica Sant Pau) ;
Fariñas-Guerrero, F. (Universidad de Málaga) ;
Jiménez-Ruiz, C.A. (Hospital Clínico San Carlos (Madrid)) ;
Universitat Autònoma de Barcelona
Immunosenescence is the gradual deterioration of the immune system caused by advancing age. It is associated with a reduced ability to respond to infections and develop long-term immune memory. It plays a key role in the development of respiratory diseases that are more common in older people, such as asthma, COPD, diffuse interstitial disease and respiratory infections in the elderly. [...]
2022 - 10.1016/j.opresp.2022.100181
Open Respiratory Archives, Vol. 4 Núm. 3 (enero 2022) , p. 100181
|
|
|
8.
|
|
10 p, 859.5 KB |
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
/
Zhang, Y. (University of Oxford) ;
Ghose, U. (University of Oxford) ;
Buckley, N.J. (University of Oxford) ;
Engelborghs, S. (Vrije Universiteit Brussel) ;
Sleegers, K. (University of Antwerp) ;
Frisoni, G.B. (Department of Psychiatry. University of Geneva) ;
Wallin, A. (University of Gothenburg) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Popp, J. (University of Zürich) ;
Martinez-Lage, P. (CITA-Alzheimer Foundation) ;
Legido-Quigley, C. (Steno Diabetes Center) ;
Barkhof, F. (University College London) ;
Zetterberg, H. (Kong Kong Center for Neurodegenerative Diseases) ;
Visser, P.J. (VU University Medical Center) ;
Bertram, L. (University of Oslo) ;
Lovestone, S. (Janssen RD) ;
Nevado-Holgado, Alejo (University of Oxford) ;
Shi, L. (University of Oxford) ;
Universitat Autònoma de Barcelona
Background and objective: Blood-based biomarkers represent a promising approach to help identify early Alzheimer's disease (AD). Previous research has applied traditional machine learning (ML) to analyze plasma omics data and search for potential biomarkers, but the most modern ML methods based on deep learning has however been scarcely explored. [...]
2022 - 10.3389/fnagi.2022.1040001
Frontiers in aging neuroscience, Vol. 14 (29 2022) , p. 1040001
|
|
|
9.
|
|
11 p, 379.4 KB |
Postoperative Chemotherapy Use and Outcomes From ADAURA : Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
/
Wu, Yi-Long (Guangdong Lung Cancer Institute) ;
John, Thomas (Austin Health) ;
Grohe, Christian (Evangelische Lungenklinik) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Goldman, Jonathan W. (University of California) ;
Kim, Sang-We (University of Ulsan) ;
Kato, Terufumi (Kanagawa Cancer Center) ;
Laktionov, Konstantin (Blokhin National Medical Research Center of Oncology) ;
Vu, Huu Vinh (Choray Hospital) ;
Wang, Zhije (Chinese Academy of Medical Sciences) ;
Lu, Shun (Shanghai Jiao Tong University) ;
Lee, Kye Young (Konkuk University Medical Center) ;
Akewanlop, Charuwan (Siriraj Hospital) ;
Yu, Chong-Jen (National Taiwan University College of Medicine) ;
de Marinis, Filippo (European Institute of Oncology) ;
Bonanno, Laura (Istituto Oncologico Veneto) ;
Domine, Manuel (Instituto de Investigación Sanitaria-Fundación Jiménez Díaz) ;
Shepherd, Frances A. (University of Toronto) ;
Zeng, Lingmin (AstraZeneca) ;
Atasoy, Ajlan (AstraZeneca) ;
Herbst, Roy S. (Yale School of Medicine) ;
Tsuboi, Masahiro (National Cancer Center Hospital East) ;
Universitat Autònoma de Barcelona
Introduction: Adjuvant chemotherapy is recommended in patients with resected stages II to IIIA (and select IB) NSCLC; however, recurrence rates are high. In the phase 3 ADAURA study (NCT02511106), osimertinib was found to have a clinically meaningful improvement in disease-free survival (DFS) in patients with resected stages IB to IIIA EGFR-mutated (EGFRm) NSCLC. [...]
2022 - 10.1016/j.jtho.2021.10.014
Journal of Thoracic Oncology, Vol. 17 Núm. 3 (march 2022) , p. 423-433
|
|
|
10.
|
|
9 p, 780.5 KB |
Flank pain has a significant adverse impact on quality of life in ADPKD : the CYSTic-QoL study
/
Winterbottom, J. (Sheffield Teaching Hospitals Nhs Foundation Trust) ;
Simms, R.J. (Sheffield Teaching Hospitals Nhs Foundation Trust) ;
Caroli, A. (Istituto di Ricerche Farmacologiche Mario Negri Irccs) ;
Cornec-Le Gall, Emilie (Brest University) ;
Demoulin, Nathalie (Université Catholique de Louvain Medical School) ;
Furlano, Monica (Institut d'Investigació Biomèdica Sant Pau) ;
Meijer, E. (University Medical Centre Groningen) ;
Devuyst, Olivier (Université Catholique de Louvain Medical School) ;
Gansevoort, R.T. (University Medical Centre Groningen) ;
Le-Meur, Y. (Brest University) ;
Perico, N. (Istituto di Ricerche Farmacologiche Mario Negri Irccs) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Ong, A.C.M. (Sheffield Teaching Hospitals Nhs Foundation Trust) ;
Universitat Autònoma de Barcelona
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder and a major cause of kidney failure worldwide. However, its impact on quality-of-life has not been systematically explored. [...]
2022 - 10.1093/ckj/sfac144
Clinical Kidney Journal, Vol. 15 Núm. 11 (january 2022) , p. 2063-2071
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
